PlainRecalls
FDA Devices Moderate Class II Terminated

Optium EZ Blood Glucose Monitoring System, UDI: 00093815710653

Reported: April 1, 2020 Initiated: November 14, 2019 #Z-1557-2020

Product Description

Optium EZ Blood Glucose Monitoring System, UDI: 00093815710653

Reason for Recall

Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.

Details

Units Affected
N/A
Distribution
U.S.: KY, NY, TN, MA, IL, SC, VT, FL, CA, NC, MS, NJ, TX, AL, GA, OK, CT, PA, NE, ND, MT, MO, DC, ME, LA, KS, ID, OH, MN, NM, VA, IN
Location
Alameda, CA

Frequently Asked Questions

What product was recalled?
Optium EZ Blood Glucose Monitoring System, UDI: 00093815710653. Recalled by Abbott Diabetes Care, Inc.. Units affected: N/A.
Why was this product recalled?
Instructions sent in a letter or in instructions for use for disinfecting blood glucose and/or ketone meters were distributed but not cleared by the U.S. FDA, and devices were not cleared for multiple-patient use. Instructions could lead to inappropriate meter disinfection or improper handling of contaminated meters, which may cause infection or exacerbation of an existing infection.
Which agency issued this recall?
This recall was issued by the FDA Devices on April 1, 2020. Severity: Moderate. Recall number: Z-1557-2020.